Latest News

  • BioAge shares plummet after trial closes

    Shares of agetech company BioAge have plummeted since the company announced the discontinuation of a Phase 2 trial for its weight-loss drug azelaprag due to safety concerns. The abrupt halt comes just a little over two months after the company raised US$198m in an initial public offering in late September. Hagens Berman has opened an [...]

  • Longevity clinic unveils advanced AI-powered services

    A longevity clinic is harnessing predictive analytics, machine learning and real-time data integration for personalised patient care. Victor Regenerative Medical Centers will utilise AI-powered tools to collect and analyse various data points ranging from medical history to genetic information and lifestyle factors. The approach is designed to help the clinic predict health risks, optimise treatment [...]

  • How DNA shapes health and life expectancy

    Researchers have conducted a review into how genetic variations can explain differences in when we have children, the timing of menopause, and how long we live. The review looked male and female genetic discoveries, identifying 159 genetic studies and 37 key genes that are linked to reproductive traits such as age at first childbirth, menopause timing, [...]

  • Half of older adults to rely on wearables for life-saving alerts by 2034 – report

    Within five to 10 years, one in two older adults will use wearable devices daily to forecast life-threatening risks, predicts new research. Researchers analysed wearable adoption trends in the US over the past decade and uncovered slower uptake among older generations. The study identifies barriers to adoption and suggests that wearable manufacturers can better address [...]

  • Halle Berry’s longevity brand unveils new focus on menopause

    Respin, the health and wellness platform founded by actress Halle Berry, has announced it is launching its female longevity platform focussed on perimenopause and menopause. Respin is a community-based platform where women can ask questions, engage in meaningful discussions, and build connections. The platform aims to provide a space where women navigating menopause and longevity [...]

  • Ageing may change some brain cells more than others

    A new study has provided a roadmap for how ageing may alter brain cell genetic activity, revealing that not all cell types in the brain age in the same way. The researchers found that some cells, such as a small group of hormone-controlling cells, may undergo more age-related changes in genetic activity than others. The [...]

  • Drinking coffee may help prevent cognitive decline in people with atrial fibrillation

    Having up to or more than five cups of coffee daily may help cognitive function in people with the irregular heart rhythm, finds a new study. A study of more than 2,400 people with atrial fibrillation, who had an average age of 73, found that drinking more than five cups of caffeinated coffee daily was [...]

  • The surprising role of gut infection in Alzheimer’s disease

    Researchers have discovered a surprising link between a chronic gut infection caused by a common virus and the development of Alzheimer’s disease in a subset of people. It is believed most humans are exposed to this virus — called cytomegalovirus or HCMV — during the first few decades of life. Cytomegalovirus is one of nine [...]

  • Rates of deaths from heart disease lower in neighbourhoods with more greenspace

    According to a recently published study, rates of deaths from heart disease — especially among men — are lower in neighbourhoods with more greenspace.  Studying heart disease deaths in Philadelphia from 2008 to 2015, the researchers also found that, contrary to their hypothesis, it was in neighbourhoods with more crime where greater park access and [...]

  • Clinical trial brings Alzheimer’s treatment one step closer

    A successful trial of  a drug for memory loss in people with Alzheimer’s disease and schizophrenia brings treatment one step closer. VU319 is the first Vanderbilt end-to-end drug discovery effort, starting from the earliest basic science research through human clinical trials. The effort spanned a high-throughput screening hit-to-candidate selection to completion of a clinical trial. [...]